ARCHIVES

Clolar Approved for Pediatric Refractory/Relapsed ALL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

ACS President Calls On Physicians To Take Advantage Of “Untapped Opportunities” In Cancer Prevention

March 27, 1987

Six Years into The Drug Shortage, And The Causes Are Still a Mystery

October 14, 2011

Funding Opportunities

January 24, 2003

NCI To Fund 840 Competing Grants In FY 1991; No Downward Negotiations, But Careful Review

December 7, 1990

NCI Budget: About Half Of Increase In President’s Budget Would Fund Grants

February 13, 1998

In Brief: Hisserich Named USC Assistant VP, Replaced By Rideout At Cancer Center; DeVita Assures Groups

June 27, 1986